GW Prescription medication CEO Justin Gover discusses how the firm secured FDA reputation of its cannabis-derived drug and what it says about the methodology ahead for cannabis-derived treatment.
GW Pharma CEO on contemporary cannabis-derived drug
Tweet on Twitter
Share on Facebook
Pinterest
